8-K: Pluri Inc. Regains Compliance with Nasdaq Listing Requirements

Pluri Inc. has regained compliance with Nasdaq Listing Rule 5550(b)(2) after demonstrating a market value of listed securities of $35 million or greater for 10 consecutive business days.

Summary

• Pluri Inc. received a deficiency letter from Nasdaq on November 25, 2024, for not meeting the minimum stockholders' equity requirement of $2,500,000.
• The company also did not meet alternative listing standards related to market value of listed securities or net income.
• Pluri submitted a compliance plan to Nasdaq on January 6, 2025, and received an extension until May 24, 2025, to regain compliance.
• On May 7, 2025, Nasdaq determined that Pluri regained compliance with Listing Rule 5550(b)(2) because the market value of its listed securities was $35 million or greater for 10 consecutive business days from April 22, 2025, through May 6, 2025.
• As a result, the matter is closed, and Pluri remains in good standing on The Nasdaq Capital Market.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the company has resolved a compliance issue and remains listed on Nasdaq. However, the initial deficiency letter indicates underlying financial challenges.

Positives

• Pluri Inc. successfully regained compliance with Nasdaq Listing Rule 5550(b)(2).
• The company remains listed on The Nasdaq Capital Market.

Negatives

• Pluri Inc. initially failed to meet Nasdaq's minimum stockholders' equity requirement and alternative listing standards.

Risks

• Failure to maintain compliance with Nasdaq listing requirements in the future could result in delisting.

Future Outlook

The company remains in good standing on The Nasdaq Capital Market.

Industry Context

Many companies, especially smaller ones, face challenges in maintaining Nasdaq listing compliance, particularly regarding minimum equity or market capitalization requirements. This announcement indicates Pluri's successful effort to address such a challenge, which is crucial for maintaining investor confidence and access to capital markets.

Comparison to Industry Standards

• Companies like Evogene Ltd. (EVGN) and Rosetta Green (ROSE) in the biotechnology sector have faced similar compliance issues with Nasdaq, requiring them to implement measures such as reverse stock splits or capital raises to meet listing requirements.
• Pluri's successful regain of compliance through market value appreciation is a positive outcome compared to companies that resort to more dilutive measures like significant equity offerings.

Stakeholder Impact

• Shareholders will likely view this news positively as it reduces the risk of delisting.
• Employees benefit from the company remaining in good standing, ensuring continued operations.

Key Dates

Keywords

Nasdaq, compliance, listing requirements, stockholders equity, market value, Pluri Inc.